Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Respiratory diseases and the impact of cough in Taiwan: Results from the APBORD observational study

Open access

Abstract

Chronic respiratory diseases such as asthma, allergic rhinitis (AR), chronic obstructive pulmonary disease (COPD), and rhinosinusitis are becoming increasingly prevalent in the Asia-Pacific region. The Asia-Pacific Burden of Respiratory Diseases (APBORD) study was a cross-sectional, observational study which examined the disease and economic burden of AR, asthma, COPD, and rhinosinusitis across Asia-Pacific using 1 standard protocol. Here we report symptoms, healthcare resource use (HCRU), work impairment, and associated cost in Taiwan.Consecutive participants aged ≥ 18 years presenting to a physician with symptoms meeting the diagnostic criteria for a primary diagnosis of asthma, AR, COPD, or rhinosinusitis were enrolled. Participants and their treating physician completed surveys detailing respiratory symptoms, HCRU, work productivity, and activity impairment. Costs including direct medical costs and indirect costs associated with lost work productivity were calculated.The study enrolled 1001 patients. AR was the most frequent primary diagnosis (31.2%). A quarter of patients presented with a combination of respiratory diseases, with AR and asthma being the most frequent combination (14.1%). Cough or coughing up phlegm was the primary reason for the medical visit for patients with asthma and COPD, whereas nasal symptoms (watery runny nose, blocked nose, and congestion) were the primary reasons for AR and rhinosinusitis. Specialists were the most frequently used healthcare resource by patients with AR (26.1%), asthma (26.4%), COPD (26.6%), and rhinosinusitis (47.3%). The mean annual cost per patient with a respiratory disease was US$4511 (SD 5395). The cost was almost double for employed patients (US$8047, SD 6175), with the majority attributable to lost productivity.Respiratory diseases have a significant impact on disease burden in Taiwan. Treatment strategies that prevent lost work productivity could greatly reduce the economic burden of these diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000003854

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Percentage of patients with a combination of diseases (N = 1001).
Figure 1 Percentage of patients with a combination of diseases (N = 1001).CC BY-ND · PubMed Central
Figure 2 Main reason for the medical visit and symptoms reported by primary diagnosis.
Figure 2 Main reason for the medical visit and symptoms reported by primary diagnosis.CC BY-ND · PubMed Central
Figure 3 Percentage of patients with HCRU in previous 4 weeks by primary diagnosis (N = 972). HCRU = healthcare resource use.
Figure 3 Percentage of patients with HCRU in previous 4 weeks by primary diagnosis (N = 972). HCRU = healthcare resource use.CC BY-ND · PubMed Central
Figure 4 History of medication use for respiratory disease and medications prescribed at the medical visit by primary diagnosis.
Figure 4 History of medication use for respiratory disease and medications prescribed at the medical visit by primary diagnosis.CC BY-ND · PubMed Central
Figure 5 Mean % WPAI scores ( ± SD) by primary diagnosis (N = 1001). SD = standard deviation, WPAI = Work Productivity and Activity Impairment.
Figure 5 Mean % WPAI scores ( ± SD) by primary diagnosis (N = 1001). SD = standard deviation, WPAI = Work Productivity and Activity Impairment.CC BY-ND · PubMed Central
Figure 6 Annual direct and indirect costs for study population by primary diagnosis (N = 1001).
Figure 6 Annual direct and indirect costs for study population by primary diagnosis (N = 1001).CC BY-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. Sun, 2008, Health care utilization and costs of adult asthma in T, aiwan, 29, 177

Cited by

See all 18

Metadata

Authors
Lin, H.-C., Cho, S.-H., Ghoshal, A. G., Muttalif, A. R. B. A., Thanaviratananich, S., Bagga, S., Faruqi, R., Sajjan, S., Cahill, C. L., Hamrosi, K. K., & Wang, D. Y.
Affiliations
  • National University of Singapore (SG)
  • Seoul National University (KR)
  • National Allergy Asthma Bronchitis Institute (IN)
  • Khon Kaen University (TH)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Corresponding author
Lin, Horng-Chyuan
Venue
Medicine
Published
2016-07
Volume
95
Issue
27
Pages
e3854
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2468479370
Cited by
18
References
30
Citations by year
2026: 1 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 2 · 2018: 4 · 2017: 2
FWCI
2.15
Type
journal article
Language
en
Open access
Licence
cc-by-nd
Locations
  • Medicine (publishedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory and Cough-Related Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
chronic respiratory disease, asthma, allergic rhinitis, chronic obstructive pulmonary disease, sinusitis, cough, economic burden, health care utilization, work productivity loss, indirect costs
MeSH terms
Asthma, Cough, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Rhinitis, Sinusitis, Taiwan, Cost of Illness, Pulmonary Disease, Chronic Obstructive, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Respiratory diseases and the impact of cough in Taiwan: Results from the APBORD observational study. https://app.cochat.ai/papers/10.1097/md.0000000000003854
The paper
Lin, H.-C., Cho, S.-H., Ghoshal, A. G., Muttalif, A. R. B. A., Thanaviratananich, S., Bagga, S., Faruqi, R., Sajjan, S., Cahill, C. L., Hamrosi, K. K., & Wang, D. Y. (2016). Respiratory diseases and the impact of cough in Taiwan: Results from the APBORD observational study. Medicine. https://doi.org/10.1097/md.0000000000003854

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.